Dendritic Cell Vaccine and Cancer Treatment: New Patents

Author(s): Andre A.R. Aleixo, Marcia A. Michelin, Eddie F.C. Murta

Journal Name: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Continued as New Advances on Endocrine Metabolic and Immune Diseases

Volume 8 , Issue 1 , 2014

Abstract:

Dendritic cell (DC) immunotherapy has been used to treat various types of tumors. Although it is already in use in clinical practice, the mechanisms through which it acts need clarification. In addition, the processes used to obtain DCs need to be improved so that more effective treatments can be offered. In this article, we present an update on the application of DC immunotherapy and the patents involved in the process.

Keywords: Cancer, dendritic cells, immunotherapy, neoplasia, new aspects, patents in immunotherapy, tumor.

promotion: free to download

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 8
ISSUE: 1
Year: 2014
Published on: 20 February, 2014
Page: [26 - 29]
Pages: 4
DOI: 10.2174/1872214807666140107152008

Article Metrics

PDF: 47